Which can Predict the Outcome of Antidepressants: Metabolic Genes or Pharmacodynamic Genes?

Moitra, M.; Santomauro, D.; Collins, P.Y.; Vos, T.; Whiteford, H.; Saxena, S.; Ferrari, A.J. The global gap in treatment coverage for major depressive disorder in 84 countries from 2000–2019: A systematic review and Bayesian meta-regression analysis. PLoS Med., 2022, 19(2), e1003901.
[http://dx.doi.org/10.1371/journal.pmed.1003901] [PMID: 35167593]

Vos, T.; Lim, S.S.; Abbafati, C.; Abbas, K.M.; Abbasi, M.; Abbasifard, M.; Abbasi-Kangevari, M.; Abbastabar, H.; Abd-Allah, F.; Abdelalim, A.; Abdollahi, M.; Abdollahpour, I.; Abolhassani, H.; Aboyans, V.; Abrams, E.M.; Abreu, L.G.; Abrigo, M.R.M.; Abu-Raddad, L.J.; Abush-ouk, A.I.; Acebedo, A.; Ackerman, I.N.; Adabi, M.; Adamu, A.A.; Adebayo, O.M.; Adekanmbi, V.; Adelson, J.D.; Adetokunboh, O.O.; Ad-ham, D.; Afshari, M.; Afshin, A.; Agardh, E.E.; Agarwal, G.; Agesa, K.M.; Aghaali, M.; Aghamir, S.M.K.; Agrawal, A.; Ahmad, T.; Ahmadi, A.; Ahmadi, M.; Ahmadieh, H.; Ahmadpour, E.; Akalu, T.Y.; Akinyemi, R.O.; Akinyemiju, T.; Akombi, B.; Al-Aly, Z.; Alam, K.; Alam, N.; Alam, S.; Alam, T.; Alanzi, T.M.; Albertson, S.B.; Alcalde-Rabanal, J.E.; Alema, N.M.; Ali, M.; Ali, S.; Alicandro, G.; Alijanzadeh, M.; Alinia, C.; Alipour, V.; Aljunid, S.M.; Alla, F.; Allebeck, P.; Almasi-Hashiani, A.; Alonso, J.; Al-Raddadi, R.M.; Altirkawi, K.A.; Alvis-Guzman, N.; Alvis-Zakzuk, N.J.; Amini, S.; Amini-Rarani, M.; Aminorroaya, A.; Amiri, F.; Amit, A.M.L.; Amugsi, D.A.; Amul, G.G.H.; Anderlini, D.; Andrei, C.L.; Andrei, T.; Anjomshoa, M.; Ansari, F.; Ansari, I.; Ansari-Moghaddam, A.; Antonio, C.A.T.; Antony, C.M.; Antriyandarti, E.; Anvari, D.; Anwer, R.; Arabloo, J.; Arab-Zozani, M.; Aravkin, A.Y.; Ariani, F.; Ärnlöv, J.; Aryal, K.K.; Arzani, A.; Asadi-Aliabadi, M.; Asa-di-Pooya, A.A.; Asghari, B.; Ashbaugh, C.; Atnafu, D.D.; Atre, S.R.; Ausloos, F.; Ausloos, M.; Ayala Quintanilla, B.P.; Ayano, G.; Ayanore, M.A.; Aynalem, Y.A.; Azari, S.; Azarian, G.; Azene, Z.N.; Babaee, E.; Badawi, A.; Bagherzadeh, M.; Bakhshaei, M.H.; Bakhtiari, A.; Bala-krishnan, S.; Balalla, S.; Balassyano, S.; Banach, M.; Banik, P.C.; Bannick, M.S.; Bante, A.B.; Baraki, A.G.; Barboza, M.A.; Barker-Collo, S.L.; Barthelemy, C.M.; Barua, L.; Barzegar, A.; Basu, S.; Baune, B.T.; Bayati, M.; Bazmandegan, G.; Bedi, N.; Beghi, E.; Béjot, Y.; Bello, A.K.; Bender, R.G.; Bennett, D.A.; Bennitt, F.B.; Bensenor, I.M.; Benziger, C.P.; Berhe, K.; Bernabe, E.; Bertolacci, G.J.; Bhageerathy, R.; Bhala, N.; Bhandari, D.; Bhardwaj, P.; Bhattacharyya, K.; Bhutta, Z.A.; Bibi, S.; Biehl, M.H.; Bikbov, B.; Bin Sayeed, M.S.; Biondi, A.; Biri-hane, B.M.; Bisanzio, D.; Bisignano, C.; Biswas, R.K.; Bohlouli, S.; Bohluli, M.; Bolla, S.R.R.; Boloor, A.; Boon-Dooley, A.S.; Borges, G.; Borzì, A.M.; Bourne, R.; Brady, O.J.; Brauer, M.; Brayne, C.; Breitborde, N.J.K.; Brenner, H.; Briant, P.S.; Briggs, A.M.; Briko, N.I.; Britton, G.B.; Bryazka, D.; Buchbinder, R.; Bumgarner, B.R.; Busse, R.; Butt, Z.A.; Caetano dos Santos, F.L.; Cámera, L.L.A.A.; Campos-Nonato, I.R.; Car, J.; Cárdenas, R.; Carreras, G.; Carrero, J.J.; Carvalho, F.; Castaldelli-Maia, J.M.; Castañeda-Orjuela, C.A.; Castelpietra, G.; Castle, C.D.; Castro, F.; Catalá-López, F.; Causey, K.; Cederroth, C.R.; Cercy, K.M.; Cerin, E.; Chandan, J.S.; Chang, A.R.; Charlson, F.J.; Chattu, V.K.; Chaturvedi, S.; Chimed-Ochir, O.; Chin, K.L.; Cho, D.Y.; Christensen, H.; Chu, D-T.; Chung, M.T.; Cicuttini, F.M.; Ciobanu, L.G.; Ci-rillo, M.; Collins, E.L.; Compton, K.; Conti, S.; Cortesi, P.A.; Costa, V.M.; Cousin, E.; Cowden, R.G.; Cowie, B.C.; Cromwell, E.A.; Cross, D.H.; Crowe, C.S.; Cruz, J.A.; Cunningham, M.; Dahlawi, S.M.A.; Damiani, G.; Dandona, L.; Dandona, R.; Darwesh, A.M.; Daryani, A.; Das, J.K.; Das Gupta, R. das Neves, J.; Dávila-Cervantes, C.A.; Davletov, K.; De Leo, D.; Dean, F.E.; DeCleene, N.K.; Deen, A.; Degenhardt, L.; Dellavalle, R.P.; Demeke, F.M.; Demsie, D.G.; Denova-Gutiérrez, E.; Dereje, N.D.; Dervenis, N.; Desai, R.; Desalew, A.; Dessie, G.A.; Dhar-maratne, S.D.; Dhungana, G.P.; Dianatinasab, M.; Diaz, D.; Dibaji Forooshani, Z.S.; Dingels, Z.V.; Dirac, M.A.; Djalalinia, S.; Do, H.T.; Dokova, K.; Dorostkar, F.; Doshi, C.P.; Doshmangir, L.; Douiri, A.; Doxey, M.C.; Driscoll, T.R.; Dunachie, S.J.; Duncan, B.B.; Duraes, A.R.; Eagan, A.W.; Ebrahimi Kalan, M.; Edvardsson, D.; Ehrlich, J.R.; El Nahas, N.; El Sayed, I.; El Tantawi, M.; Elbarazi, I.; Elgendy, I.Y.; El-habashy, H.R.; El-Jaafary, S.I.; Elyazar, I.R.F.; Emamian, M.H.; Emmons-Bell, S.; Erskine, H.E.; Eshrati, B.; Eskandarieh, S.; Esmaeilnejad, S.; Esmaeilzadeh, F.; Esteghamati, A.; Estep, K.; Etemadi, A.; Etisso, A.E.; Farahmand, M.; Faraj, A.; Fareed, M.; Faridnia, R.; Farinha, C.S.S.; Farioli, A.; Faro, A.; Faruque, M.; Farzadfar, F.; Fattahi, N.; Fazlzadeh, M.; Feigin, V.L.; Feldman, R.; Fereshtehnejad, S-M.; Fer-nandes, E.; Ferrari, A.J.; Ferreira, M.L.; Filip, I.; Fischer, F.; Fisher, J.L.; Fitzgerald, R.; Flohr, C.; Flor, L.S.; Foigt, N.A.; Folayan, M.O.; Force, L.M.; Fornari, C.; Foroutan, M.; Fox, J.T.; Freitas, M.; Fu, W.; Fukumoto, T.; Furtado, J.M.; Gad, M.M.; Gakidou, E.; Galles, N.C.; Gallus, S.; Gamkrelidze, A.; Garcia-Basteiro, A.L.; Gardner, W.M.; Geberemariyam, B.S.; Gebrehiwot, A.M.; Gebremedhin, K.B.; Gebres-lassie, A.A.A.A.; Gershberg Hayoon, A.; Gething, P.W.; Ghadimi, M.; Ghadiri, K.; Ghafourifard, M.; Ghajar, A.; Ghamari, F.; Ghashghaee, A.; Ghiasvand, H.; Ghith, N.; Gholamian, A.; Gilani, S.A.; Gill, P.S.; Gitimoghaddam, M.; Giussani, G.; Goli, S.; Gomez, R.S.; Gopalani, S.V.; Gorini, G.; Gorman, T.M.; Gottlich, H.C.; Goudarzi, H.; Goulart, A.C.; Goulart, B.N.G.; Grada, A.; Grivna, M.; Grosso, G.; Gubari, M.I.M.; Gugnani, H.C.; Guimaraes, A.L.S.; Guimarães, R.A.; Guled, R.A.; Guo, G.; Guo, Y.; Gupta, R.; Haagsma, J.A.; Haddock, B.; Hafezi-Nejad, N.; Hafiz, A.; Hagins, H.; Haile, L.M.; Hall, B.J.; Halvaei, I.; Hamadeh, R.R.; Hamagharib Abdullah, K.; Hamilton, E.B.; Han, C.; Han, H.; Hankey, G.J.; Haro, J.M.; Harvey, J.D.; Hasaballah, A.I.; Hasanzadeh, A.; Hashemian, M.; Hassanipour, S.; Hassankhani, H.; Havmoeller, R.J.; Hay, R.J.; Hay, S.I.; Hayat, K.; Heidari, B.; Heidari, G.; Heidari-Soureshjani, R.; Hendrie, D.; Henrikson, H.J.; Henry, N.J.; Herteliu, C.; Heydarpour, F.; Hird, T.R.; Hoek, H.W.; Hole, M.K.; Holla, R.; Hoogar, P.; Hosgood, H.D.; Hosseinzadeh, M.; Hostiuc, M.; Hostiuc, S.; Househ, M.; Hoy, D.G.; Hsairi, M.; Hsieh, V.C.; Hu, G.; Huda, T.M.; Hugo, F.N.; Huynh, C.K.; Hwang, B-F.; Iannucci, V.C.; Ibitoye, S.E.; Ikuta, K.S.; Ilesanmi, O.S.; Ilic, I.M.; Ilic, M.D.; Inbaraj, L.R.; Ippolito, H.; Irvani, S.S.N.; Islam, M.M.; Islam, M.M.; Islam, S.M.S.; Islami, F.; Iso, H.; Ivers, R.Q.; Iwu, C.C.D.; Iyamu, I.O.; Jaafari, J.; Jacobsen, K.H.; Jadidi-Niaragh, F.; Jafari, H.; Jafarinia, M.; Jahagirdar, D.; Jahani, M.A.; Jahanmehr, N.; Jakovljevic, M.; Jalali, A.; Jalilian, F.; James, S.L.; Janjani, H.; Janodia, M.D.; Jayatilleke, A.U.; Jeemon, P.; Jenabi, E.; Jha, R.P.; Jha, V.; Ji, J.S.; Jia, P.; John, O.; John-Akinola, Y.O.; Johnson, C.O.; Johnson, S.C.; Jonas, J.B.; Joo, T.; Joshi, A.; Jozwiak, J.J.; Jürisson, M.; Kabir, A.; Kabir, Z.; Kalani, H.; Kalani, R.; Kalankesh, L.R.; Kalhor, R.; Kamiab, Z.; Kanchan, T.; Karami Matin, B.; Karch, A.; Karim, M.A.; Karimi, S.E.; Kassa, G.M.; Kassebaum, N.J.; Katikireddi, S.V.; Kawakami, N.; Kayode, G.A.; Keddie, S.H.; Keller, C.; Kereselidze, M.; Khafaie, M.A.; Khalid, N.; Khan, M.; Khatab, K.; Khater, M.M.; Khatib, M.N.; Khayamzadeh, M.; Khodayari, M.T.; Khund-kar, R.; Kianipour, N.; Kieling, C.; Kim, D.; Kim, Y-E.; Kim, Y.J.; Kimokoti, R.W.; Kisa, A.; Kisa, S.; Kissimova-Skarbek, K.; Kivimäki, M.; Kneib, C.J.; Knudsen, A.K.S.; Kocarnik, J.M.; Kolola, T.; Kopec, J.A.; Kosen, S.; Koul, P.A.; Koyanagi, A.; Kravchenko, M.A.; Krishan, K.; Krohn, K.J.; Kuate Defo, B.; Kucuk Bicer, B.; Kumar, G.A.; Kumar, M.; Kumar, P.; Kumar, V.; Kumaresh, G.; Kurmi, O.P.; Kusuma, D.; Kyu, H.H.; La Vecchia, C.; Lacey, B.; Lal, D.K.; Lalloo, R.; Lam, J.O.; Lami, F.H.; Landires, I.; Lang, J.J.; Lansingh, V.C.; Larson, S.L.; Larsson, A.O.; Lasrado, S.; Lassi, Z.S.; Lau, K.M-M.; Lavados, P.M.; Lazarus, J.V.; Ledesma, J.R.; Lee, P.H.; Lee, S.W.H.; LeGrand, K.E.; Leigh, J.; Leonardi, M.; Lescinsky, H.; Leung, J.; Levi, M.; Lewington, S.; Li, S.; Lim, L-L.; Lin, C.; Lin, R-T.; Linehan, C.; Linn, S.; Liu, H-C.; Liu, S.; Liu, Z.; Looker, K.J.; Lopez, A.D.; Lopukhov, P.D.; Lorkowski, S.; Lotufo, P.A.; Lucas, T.C.D.; Lugo, A.; Lunevicius, R.; Lyons, R.A.; Ma, J.; MacLachlan, J.H.; Maddison, E.R.; Maddison, R.; Madotto, F.; Mahasha, P.W.; Mai, H.T.; Majeed, A.; Maled, V.; Maleki, S.; Malekzadeh, R.; Malta, D.C.; Mamun, A.A.; Manafi, A.; Manafi, N.; Manguerra, H.; Mansouri, B.; Mansournia, M.A.; Mantilla Herrera, A.M.; Maravilla, J.C.; Marks, A.; Martins-Melo, F.R.; Martopullo, I.; Masoumi, S.Z.; Massano, J.; Massenburg, B.B.; Mathur, M.R.; Maulik, P.K.; McAlinden, C.; McGrath, J.J.; McKee, M.; Mehndiratta, M.M.; Mehri, F.; Mehta, K.M.; Meitei, W.B.; Memiah, P.T.N.; Mendoza, W.; Menezes, R.G.; Mengesha, E.W.; Mengesha, M.B.; Mereke, A.; Meretoja, A.; Meretoja, T.J.; Mestrovic, T.; Miazgowski, B.; Miazgowski, T.; Michalek, I.M.; Mihretie, K.M.; Miller, T.R.; Mills, E.J.; Mirica, A.; Mirrakhimov, E.M.; Mirzaei, H.; Mirzaei, M.; Mirzaei-Alavijeh, M.; Mis-ganaw, A.T.; Mithra, P.; Moazen, B.; Moghadaszadeh, M.; Mohamadi, E.; Mohammad, D.K.; Mohammad, Y.; Mohammad Gholi Mezerji, N.; Mohammadian-Hafshejani, A.; Mohammadifard, N.; Mohammadpourhodki, R.; Mohammed, S.; Mokdad, A.H.; Molokhia, M.; Momen, N.C.; Monasta, L.; Mondello, S.; Mooney, M.D.; Moosazadeh, M.; Moradi, G.; Moradi, M.; Moradi-Lakeh, M.; Moradzadeh, R.; Moraga, P.; Morales, L.; Morawska, L.; Moreno Velásquez, I.; Morgado-da-Costa, J.; Morrison, S.D.; Mosser, J.F.; Mouodi, S.; Mousavi, S.M.; Mousavi Khaneghah, A.; Mueller, U.O.; Munro, S.B.; Muriithi, M.K.; Musa, K.I.; Muthupandian, S.; Naderi, M.; Nagarajan, A.J.; Nagel, G.; Naghshta-brizi, B.; Nair, S.; Nandi, A.K.; Nangia, V.; Nansseu, J.R.; Nayak, V.C.; Nazari, J.; Negoi, I.; Negoi, R.I.; Netsere, H.B.N.; Ngunjiri, J.W.; Ngu-yen, C.T.; Nguyen, J.; Nguyen, M.; Nguyen, M.; Nichols, E.; Nigatu, D.; Nigatu, Y.T.; Nikbakhsh, R.; Nixon, M.R.; Nnaji, C.A.; Nomura, S.; Norrving, B.; Noubiap, J.J.; Nowak, C.; Nunez-Samudio, V.; Oţoiu, A.; Oancea, B.; Odell, C.M.; Ogbo, F.A.; Oh, I-H.; Okunga, E.W.; Oladna-bi, M.; Olagunju, A.T.; Olusanya, B.O.; Olusanya, J.O.; Oluwasanu, M.M.; Omar Bali, A.; Omer, M.O.; Ong, K.L.; Onwujekwe, O.E.; Orji, A.U.; Orpana, H.M.; Ortiz, A.; Ostroff, S.M.; Otstavnov, N.; Otstavnov, S.S.; Øverland, S.; Owolabi, M.O.; P A, M.; Padubidri, J.R.; Pakhare, A.P.; Palladino, R.; Pana, A.; Panda-Jonas, S.; Pandey, A.; Park, E-K.; Parmar, P.G.K.; Pasupula, D.K.; Patel, S.K.; Paternina-Caicedo, A.J.; Pathak, A.; Pathak, M.; Patten, S.B.; Patton, G.C.; Paudel, D.; Pazoki Toroudi, H.; Peden, A.E.; Pennini, A.; Pepito, V.C.F.; Peprah, E.K.; Pe-reira, A.; Pereira, D.M.; Perico, N.; Pham, H.Q.; Phillips, M.R.; Pigott, D.M.; Pilgrim, T.; Pilz, T.M.; Pirsaheb, M.; Plana-Ripoll, O.; Plass, D.; Pokhrel, K.N.; Polibin, R.V.; Polinder, S.; Polkinghorne, K.R.; Postma, M.J.; Pourjafar, H.; Pourmalek, F.; Pourmirza Kalhori, R.; Pourshams, A.; Poznańska, A.; Prada, S.I.; Prakash, V.; Pribadi, D.R.A.; Pupillo, E.; Quazi Syed, Z.; Rabiee, M.; Rabiee, N.; Radfar, A.; Rafiee, A.; Rafiei, A.; Raggi, A.; Rahimi-Movaghar, A.; Rahman, M.A.; Rajabpour-Sanati, A.; Rajati, F.; Ramezanzadeh, K.; Ranabhat, C.L.; Rao, P.C.; Rao, S.J.; Rasella, D.; Rastogi, P.; Rathi, P.; Rawaf, D.L.; Rawaf, S.; Rawal, L.; Razo, C.; Redford, S.B.; Reiner, R.C., Jr; Reinig, N.; Reitsma, M.B.; Remuzzi, G.; Renjith, V.; Renzaho, A.M.N.; Resnikoff, S.; Rezaei, N.; Rezai, M.; Rezapour, A.; Rhinehart, P-A.; Riahi, S.M.; Ribeiro, A.L.P.; Ribeiro, D.C.; Ribeiro, D.; Rickard, J.; Roberts, N.L.S.; Roberts, S.; Robinson, S.R.; Roever, L.; Rolfe, S.; Ronfani, L.; Roshandel, G.; Roth, G.A.; Rubagotti, E.; Rumisha, S.F.; Sabour, S.; Sachdev, P.S.; Saddik, B.; Sadeghi, E.; Sadeghi, M.; Saeidi, S.; Safi, S.; Safiri, S.; Sagar, R.; Sa-hebkar, A.; Sahraian, M.A.; Sajadi, S.M.; Salahshoor, M.R.; Salamati, P.; Salehi Zahabi, S.; Salem, H.; Salem, M.R.R.; Salimzadeh, H.; Salo-mon, J.A.; Salz, I.; Samad, Z.; Samy, A.M.; Sanabria, J.; Santomauro, D.F.; Santos, I.S.; Santos, J.V.; Santric-Milicevic, M.M.; Saraswathy, S.Y.I.; Sarmiento-Suárez, R.; Sarrafzadegan, N.; Sartorius, B.; Sarveazad, A.; Sathian, B.; Sathish, T.; Sattin, D.; Sbarra, A.N.; Schaeffer, L.E.; Schiavolin, S.; Schmidt, M.I.; Schutte, A.E.; Schwebel, D.C.; Schwendicke, F.; Senbeta, A.M.; Senthilkumaran, S.; Sepanlou, S.G.; Shackel-ford, K.A.; Shadid, J.; Shahabi, S.; Shaheen, A.A.; Shaikh, M.A.; Shalash, A.S.; Shams-Beyranvand, M.; Shamsizadeh, M.; Shannawaz, M.; Sharafi, K.; Sharara, F.; Sheena, B.S.; Sheikhtaheri, A.; Shetty, R.S.; Shibuya, K.; Shiferaw, W.S.; Shigematsu, M.; Shin, J.I.; Shiri, R.; Shirkoohi, R.; Shrime, M.G.; Shuval, K.; Siabani, S.; Sigfusdottir, I.D.; Sigurvinsdottir, R.; Silva, J.P.; Simpson, K.E.; Singh, A.; Singh, J.A.; Skiadaresi, E.; Skou, S.T.; Skryabin, V.Y.; Sobngwi, E.; Sokhan, A.; Soltani, S.; Sorensen, R.J.D.; Soriano, J.B.; Sorrie, M.B.; Soyiri, I.N.; Sreeramareddy, C.T.; Stanaway, J.D.; Stark, B.A.; Ştefan, S.C.; Stein, C.; Steiner, C.; Steiner, T.J.; Stokes, M.A.; Stovner, L.J.; Stubbs, J.L.; Sudaryanto, A.; Sufiyan, M.B.; Sulo, G.; Sultan, I.; Sykes, B.L.; Sylte, D.O.; Szócska, M.; Tabarés-Seisdedos, R.; Tabb, K.M.; Tadakamadla, S.K.; Taherkhani, A.; Tajdini, M.; Takahashi, K.; Taveira, N.; Teagle, W.L.; Teame, H.; Tehrani-Banihashemi, A.; Teklehaimanot, B.F.; Ter-rason, S.; Tessema, Z.T.; Thankappan, K.R.; Thomson, A.M.; Tohidinik, H.R.; Tonelli, M.; Topor-Madry, R.; Torre, A.E.; Touvier, M.; To-vani-Palone, M.R.R.; Tran, B.X.; Travillian, R.; Troeger, C.E.; Truelsen, T.C.; Tsai, A.C.; Tsatsakis, A.; Tudor Car, L.; Tyrovolas, S.; Uddin, R.; Ullah, S.; Undurraga, E.A.; Unnikrishnan, B.; Vacante, M.; Vakilian, A.; Valdez, P.R.; Varughese, S.; Vasankari, T.J.; Vasseghian, Y.; Venketasubramanian, N.; Violante, F.S.; Vlassov, V.; Vollset, S.E.; Vongpradith, A.; Vukovic, A.; Vukovic, R.; Waheed, Y.; Walters, M.K.; Wang, J.; Wang, Y.; Wang, Y-P.; Ward, J.L.; Watson, A.; Wei, J.; Weintraub, R.G.; Weiss, D.J.; Weiss, J.; Westerman, R.; Whisnant, J.L.; Whiteford, H.A.; Wiangkham, T.; Wiens, K.E.; Wijeratne, T.; Wilner, L.B.; Wilson, S.; Wojtyniak, B.; Wolfe, C.D.A.; Wool, E.E.; Wu, A-M.; Wulf Hanson, S.; Wunrow, H.Y.; Xu, G.; Xu, R.; Yadgir, S.; Yahyazadeh Jabbari, S.H.; Yamagishi, K.; Yaminfirooz, M.; Yano, Y.; Yaya, S.; Yazdi-Feyzabadi, V.; Yearwood, J.A.; Yeheyis, T.Y.; Yeshitila, Y.G.; Yip, P.; Yonemoto, N.; Yoon, S-J.; Yoosefi Lebni, J.; Younis, M.Z.; Younker, T.P.; Yousefi, Z.; Yousefifard, M.; Yousefinezhadi, T.; Yousuf, A.Y.; Yu, C.; Yusefzadeh, H.; Zahirian Moghadam, T.; Zaki, L.; Zaman, S.B.; Zamani, M.; Zamanian, M.; Zandian, H.; Zangeneh, A.; Zastrozhin, M.S.; Zewdie, K.A.; Zhang, Y.; Zhang, Z-J.; Zhao, J.T.; Zhao, Y.; Zheng, P.; Zhou, M.; Ziapour, A.; Zimsen, S.R.M.; Naghavi, M.; Murray, C.J.L. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the global burden of disease study 2019. Lancet, 2020, 396(10258), 1204-1222.
[http://dx.doi.org/10.1016/S0140-6736(20)30925-9] [PMID: 33069326]

Kennedy, S.H.; Lam, R.W.; McIntyre, R.S.; Tourjman, S.V.; Bhat, V.; Blier, P.; Hasnain, M.; Jollant, F.; Levitt, A.J.; MacQueen, G.M.; McIn-erney, S.J.; McIntosh, D.; Milev, R.V.; Müller, D.J.; Parikh, S.V.; Pearson, N.L.; Ravindran, A.V.; Uher, R. Canadian network for mood and anxiety treatments (canmat) 2016 clinical guidelines for the management of adults with major depressive disorder. Can. J. Psychiatry, 2016, 61(9), 540-560.
[http://dx.doi.org/10.1177/0706743716659417] [PMID: 27486148]

Zhao, Q.; Fu, B.; Lyu, N.; Xu, X.; Huang, G.; Tan, Y.; Xu, X.; Zhang, X.; Wang, X.; Wang, Z.; Li, K.; Hu, Z.; Li, H.; He, H.; Li, S.; Zhao, J.; He, R.; Guo, H.; Li, Y.; Li, L.; Yang, C.; Zou, S.; Wei, B.; Wang, W.; Chen, C.; Lu, Z.; He, S.; Wang, Q.; Zhao, J.; Pan, X.; Pan, Z.; Li, J.; Wang, G. A multicenter, randomized, double-blind, duloxetine-controlled, non-inferiority trial of desvenlafaxine succinate extended-release in patients with major depressive disorder. J. Affect. Disord., 2023, 329, 72-80.
[http://dx.doi.org/10.1016/j.jad.2023.02.067] [PMID: 36813043]

Wang, G.; Xiao, L.; Ren, H.; Simonsen, K.; Ma, J.; Xu, X.; Guo, P.; Wang, Z.; Bai, L.; Heldbo Reines, E.; Hammer-Helmich, L. Effectiveness and safety of vortioxetine for major depressive disorder in real-world clinical practice: Results from the single-arm relieve china study. Neuropsychiatr. Dis. Treat., 2022, 18, 1939-1950.
[http://dx.doi.org/10.2147/NDT.S358253] [PMID: 36065389]

Wang, G.; Han, C.; Liu, C.Y.; Chan, S.; Kato, T.; Tan, W.; Zhang, L.; Feng, Y.; Ng, C.H. Management of treatment-resistant depression in real-world clinical practice settings across asia. Neuropsychiatr. Dis. Treat., 2020, 16, 2943-2959.
[http://dx.doi.org/10.2147/NDT.S264813] [PMID: 33299316]

Warden, D.; Rush, A.J.; Trivedi, M.H.; Fava, M.; Wisniewski, S.R. The STAR*D project results: A comprehensive review of findings. Curr. Psychiatry Rep., 2007, 9(6), 449-459.
[http://dx.doi.org/10.1007/s11920-007-0061-3] [PMID: 18221624]

Ren, F.; Ma, Y.; Zhu, X.; Guo, R.; Wang, J.; He, L. Pharmacogenetic association of bi- and triallelic polymorphisms of SLC6A4 with antide-pressant response in major depressive disorder. J. Affect. Disord., 2020, 273, 254-264.
[http://dx.doi.org/10.1016/j.jad.2020.04.058] [PMID: 32421611]

Brignone, M.; Diamand, F.; Painchault, C.; Takyar, S. Efficacy and tolerability of switching therapy to vortioxetine versus other antidepres-sants in patients with major depressive disorder. Curr. Med. Res. Opin., 2016, 32(2), 351-366.
[http://dx.doi.org/10.1185/03007995.2015.1128404] [PMID: 26637048]

Gillett, G.; Tomlinson, A.; Efthimiou, O.; Cipriani, A. Predicting treatment effects in unipolar depression: A meta-review. Pharmacol. Ther., 2020, 212, 107557.
[http://dx.doi.org/10.1016/j.pharmthera.2020.107557] [PMID: 32437828]

Perlman, K.; Benrimoh, D.; Israel, S.; Rollins, C.; Brown, E.; Tunteng, J.F.; You, R.; You, E.; Tanguay-Sela, M.; Snook, E.; Miresco, M.; Berlim, M.T. A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder. J. Affect. Disord., 2019, 243, 503-515.
[http://dx.doi.org/10.1016/j.jad.2018.09.067] [PMID: 30286415]

Lauschke, V.M.; Zhou, Y.; Ingelman-Sundberg, M. Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity. Pharmacol. Ther., 2019, 197, 122-152.
[http://dx.doi.org/10.1016/j.pharmthera.2019.01.002] [PMID: 30677473]

Lauschke, V.M.; Ingelman-Sundberg, M. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Se-quencing. Eur. J. Pharm. Sci., 2019, 130, 65-77.
[http://dx.doi.org/10.1016/j.ejps.2019.01.024] [PMID: 30684656]

Tansey, K.E.; Guipponi, M.; Hu, X.; Domenici, E.; Lewis, G.; Malafosse, A.; Wendland, J.R.; Lewis, C.M.; McGuffin, P.; Uher, R. Contribu-tion of common genetic variants to antidepressant response. Biol. Psychiatry, 2013, 73(7), 679-682.
[http://dx.doi.org/10.1016/j.biopsych.2012.10.030] [PMID: 23237317]

Milosavljevic, F.; Bukvic, N.; Pavlovic, Z.; Miljevic, C.; Pešic, V.; Molden, E.; Ingelman-Sundberg, M.; Leucht, S.; Jukic, M.M. Association of CYP2C19 and CYP2D6 poor and intermediate metabolizer status with antidepressant and antipsychotic exposure. JAMA Psychiatry, 2021, 78(3), 270-280.
[http://dx.doi.org/10.1001/jamapsychiatry.2020.3643] [PMID: 33237321]

Culverhouse, R.C.; Saccone, N.L.; Horton, A.C.; Ma, Y.; Anstey, K.J.; Banaschewski, T.; Burmeister, M.; Cohen-Woods, S.; Etain, B.; Fisher, H.L.; Goldman, N.; Guillaume, S.; Horwood, J.; Juhasz, G.; Lester, K.J.; Mandelli, L.; Middeldorp, C.M.; Olié, E.; Villafuerte, S.; Air, T.M.; Araya, R.; Bowes, L.; Burns, R.; Byrne, E.M.; Coffey, C.; Coventry, W.L.; Gawronski, K A B.; Glei, D.; Hatzimanolis, A.; Hottenga, J-J.; Jaussent, I.; Jawahar, C.; Jennen-Steinmetz, C.; Kramer, J.R.; Lajnef, M.; Little, K.; zu Schwabedissen, H.M.; Nauck, M.; Nederhof, E.; Petschner, P.; Peyrot, W.J.; Schwahn, C.; Sinnamon, G.; Stacey, D.; Tian, Y.; Toben, C.; Van der Auwera, S.; Wainwright, N.; Wang, J-C.; Wil-lemsen, G.; Anderson, I.M.; Arolt, V.; Åslund, C.; Bagdy, G.; Baune, B.T.; Bellivier, F.; Boomsma, D.I.; Courtet, P.; Dannlowski, U.; de Geus, E.J.C.; Deakin, J F W.; Easteal, S.; Eley, T.; Fergusson, D.M.; Goate, A.M.; Gonda, X.; Grabe, H.J.; Holzman, C.; Johnson, E.O.; Ken-nedy, M.; Laucht, M.; Martin, N.G.; Munafò, M.R.; Nilsson, K.W.; Oldehinkel, A.J.; Olsson, C.A.; Ormel, J.; Otte, C.; Patton, G.C.; Penninx, B.W.J.H.; Ritchie, K.; Sarchiapone, M.; Scheid, J.M.; Serretti, A.; Smit, J.H.; Stefanis, N.C.; Surtees, P.G.; Völzke, H.; Weinstein, M.; Whooley, M.; Nurnberger, J.I., Jr; Breslau, N.; Bierut, L.J. Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. Mol. Psychiatry, 2018, 23(1), 133-142.
[http://dx.doi.org/10.1038/mp.2017.44] [PMID: 28373689]

Hiemke, C.; Bergemann, N.; Clement, H.W.; Conca, A.; Deckert, J.; Domschke, K.; Eckermann, G.; Egberts, K.; Gerlach, M.; Greiner, C.; Gründer, G.; Haen, E.; Havemann-Reinecke, U.; Hefner, G.; Helmer, R.; Janssen, G.; Jaquenoud, E.; Laux, G.; Messer, T.; Mössner, R.; Müller, M.J.; Paulzen, M.; Pfuhlmann, B.; Riederer, P.; Saria, A.; Schoppek, B.; Schoretsanitis, G.; Schwarz, M.; Gracia, M.S.; Stegmann, B.; Steimer, W.; Stingl, J.C.; Uhr, M.; Ulrich, S.; Unterecker, S.; Waschgler, R.; Zernig, G.; Zurek, G.; Baumann, P. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology:Update 2017. Pharmacopsychiatry, 2018, 1(1-02), 9-62.

Jukić, M.M.; Haslemo, T.; Molden, E.; Ingelman-Sundberg, M. Impact of CYP2C19 genotype on escitalopram exposure and therapeutic fail-ure: A retrospective study based on 2,087 patients. Am. J. Psychiatry, 2018, 175(5), 463-470.
[http://dx.doi.org/10.1176/appi.ajp.2017.17050550] [PMID: 29325448]

Furukawa, T.A.; Cipriani, A.; Cowen, P.J.; Leucht, S.; Egger, M.; Salanti, G. Optimal dose of selective serotonin reuptake inhibitors, venlafax-ine, and mirtazapine in major depression: A systematic review and dose-response meta-analysis. Focus Am. Psychiatr. Publ., 2020, 18(2), 211-219.
[http://dx.doi.org/10.1176/appi.focus.18204] [PMID: 33343239]

Fabbri, C.; Zohar, J.; Serretti, A. Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2018, 86, 36-44.
[http://dx.doi.org/10.1016/j.pnpbp.2018.05.007] [PMID: 29777729]

Table of pharmacogenomic biomarkers in drug labeling. 2022. Avaialble from: https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling

Taylor, C.; Crosby, I.; Yip, V.; Maguire, P.; Pirmohamed, M.; Turner, R.M. A review of the important role of CYP2D6 in pharmacogenomics. Genes, 2020, 11(11), 1295.
[http://dx.doi.org/10.3390/genes11111295] [PMID: 33143137]

Zemanova, N.; Anzenbacher, P.; Anzenbacherova, E. The role of cytochromes P450 in the metabolism of selected antidepressants and anxio-lytics under psychological stress. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 2022, 166(2), 140-149.
[http://dx.doi.org/10.5507/bp.2022.019] [PMID: 35438085]

Oz, M.D.; Baskak, B.; Uckun, Z.; Artun, N.Y.; Ozdemir, H.; Ozel, T.K.; Ozguven, H.D.; Suzen, H.S. Association between serotonin 2A recep-tor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients. Pharmacogenomics J., 2020, 20(3), 443-450.
[http://dx.doi.org/10.1038/s41397-019-0127-8] [PMID: 31792367]

van der Schans, J.; Hak, E.; Postma, M.; Breuning, L.; Brouwers, J.R.B.J.; Ditters, K.; Jansen, P.A.F.; Kok, R.M.; Maring, J.G.; van Marum, R.; Mulder, H.; Nanninga, J.; Oude Voshaar, R.C.; Risselada, A.J.; Vleugel, L.; Stek, M.; van Schaik, R.H.N.; Berm, E.J.J.; Wilffert, B. Effects of pharmacogenetic screening for cyp2d6 among elderly starting therapy with nortriptyline or venlafaxine. J. Clin. Psychopharmacol., 2019, 39(6), 583-590.
[http://dx.doi.org/10.1097/JCP.0000000000001129] [PMID: 31688392]

Thürmann, P.A. Pharmacodynamics and pharmacokinetics in older adults. Curr. Opin. Anaesthesiol., 2020, 33(1), 109-113.
[http://dx.doi.org/10.1097/ACO.0000000000000814] [PMID: 31789903]

Ahmed, A.T.; Biernacka, J.M.; Jenkins, G.; Rush, A.J.; Shinozaki, G.; Veldic, M.; Kung, S.; Bobo, W.V.; Hall-Flavin, D.K.; Weinshilboum, R.M.; Wang, L.; Frye, M.A. Pharmacokinetic-pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram/escitalopram treatment failure. J. Affect. Disord., 2019, 246, 62-68.
[http://dx.doi.org/10.1016/j.jad.2018.12.021] [PMID: 30578947]

Rahikainen, A.L.; Vauhkonen, P.; Pett, H.; Palo, J.U.; Haukka, J.; Ojanperä, I.; Niemi, M.; Sajantila, A. Completed suicides of citalopram users-the role of CYP genotypes and adverse drug interactions. Int. J. Legal Med., 2019, 133(2), 353-363.
[http://dx.doi.org/10.1007/s00414-018-1927-0] [PMID: 30173302]

Aldrich, S.L.; Poweleit, E.A.; Prows, C.A.; Martin, L.J.; Strawn, J.R.; Ramsey, L.B. Influence of CYP2C19 metabolizer status on escital-opram/citalopram tolerability and response in youth with anxiety and depressive disorders. Front. Pharmacol., 2019, 10, 99.
[http://dx.doi.org/10.3389/fphar.2019.00099] [PMID: 30837874]

Claudio-Campos, K.; Padrón, A.; Jerkins, G.; Nainaparampil, J.; Nelson, R.; Martin, A.; Wiisanen, K.; Smith, D.M.; Strekalova, Y.; Marsiske, M.; Cicali, E.J.; Cavallari, L.H.; Mathews, C.A. Acceptability, feasibility, and utility of integrating pharmacogenetic testing into a child psychi-atry clinic. Clin. Transl. Sci., 2021, 14(2), 589-598.
[http://dx.doi.org/10.1111/cts.12914] [PMID: 33166056]

Saiz-Rodríguez, M.; Belmonte, C.; Román, M.; Ochoa, D.; Koller, D.; Talegón, M.; Ovejero-Benito, M.C.; López-Rodríguez, R.; Cabaleiro, T.; Abad-Santos, F. Effect of polymorphisms on the pharmacokinetics, pharmacodynamics and safety of sertraline in healthy volunteers. Basic Clin. Pharmacol. Toxicol., 2018, 122(5), 501-511.
[http://dx.doi.org/10.1111/bcpt.12938] [PMID: 29136336]

Kharasch, E.D.; Crafford, A. Common polymorphisms of cyp2b6 influence stereoselective bupropion disposition. Clin. Pharmacol. Ther., 2019, 105(1), 142-152.
[http://dx.doi.org/10.1002/cpt.1116] [PMID: 29756345]

Serretti, A.; Calati, R.; Massat, I.; Linotte, S.; Kasper, S.; Lecrubier, Y.; Sens-Espel, R.; Bollen, J.; Zohar, J.; Berlo, J.; Lienard, P.; De Ronchi, D.; Mendlewicz, J.; Souery, D. Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and re-mission in a sample of depressive patients. Int. Clin. Psychopharmacol., 2009, 24(5), 250-256.
[http://dx.doi.org/10.1097/YIC.0b013e32832e5b0d] [PMID: 19593158]

Zhu, Y.; Zhang, N.; Ren, D.; Bi, Y.; Xu, F.; Niu, W.; Sun, Q.; Guo, Z.; Yuan, R.; Yuan, F.; Wu, X.; Cao, Y.; Yang, F.; Wang, L.; Du, L.; Li, W.; Xu, Y.; Li, X.; Zhu, L.; He, L.; Shi, L.; He, G.; Yu, T. CYP1A2 genetic polymorphism is associated with treatment remission to antide-pressant venlafaxine in han chinese population. Clin. Neuropharmacol., 2019, 42(2), 32-36.
[http://dx.doi.org/10.1097/WNF.0000000000000322] [PMID: 30875344]

Elias, E.; Zhang, A.Y.; Manners, M.T. Novel pharmacological approaches to the treatment of depression. Life, 2022, 12(2), 196.
[http://dx.doi.org/10.3390/life12020196] [PMID: 35207483]

He, T.; Wu, Z.; Zhang, X.; Liu, H.; Wang, Y.; Jiang, R.; Liu, C.; Hashimoto, K.; Yang, C. A bibliometric analysis of research on the role of BDNF in depression and treatment. Biomolecules, 2022, 12(10), 1464.
[http://dx.doi.org/10.3390/biom12101464] [PMID: 36291673]

Stachowicz, K.; Sowa-Kućma, M. The treatment of depression: Searching for new ideas. Front. Pharmacol., 2022, 13, 988648.
[http://dx.doi.org/10.3389/fphar.2022.988648] [PMID: 36278184]

Jameson, A.; Fylan, B.; Bristow, G.C.; Sagoo, G.S.; Dalton, C.; Cardno, A.; Sohal, J.; McLean, S.L. What are the barriers and enablers to the implementation of pharmacogenetic testing in mental health care settings? Front. Genet., 2021, 12, 740216.
[http://dx.doi.org/10.3389/fgene.2021.740216] [PMID: 34630531]

Stein, K.; Maruf, A.A.; Müller, D.J.; Bishop, J.R.; Bousman, C.A. Serotonin transporter genetic variation and antidepressant response and tolerability: A systematic review and meta-analysis. J. Pers. Med., 2021, 11(12), 1334.
[http://dx.doi.org/10.3390/jpm11121334] [PMID: 34945806]

Lesch, K.P.; Bengel, D.; Heils, A.; Sabol, S.Z.; Greenberg, B.D.; Petri, S.; Benjamin, J.; Müller, C.R.; Hamer, D.H.; Murphy, D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 1996, 274(5292), 1527-1531.
[http://dx.doi.org/10.1126/science.274.5292.1527] [PMID: 8929413]

Kao, W.T.; Chang, C.L.; Lung, F.W. 5-HTT mRNA level as a potential biomarker of treatment response in patients with major depression in a clinical trial. J. Affect. Disord., 2018, 238, 597-608.
[http://dx.doi.org/10.1016/j.jad.2018.06.035] [PMID: 29957477]

Gulfishan, S.; Halder, S.; Kar, R.; Srivastava, S.; Gupta, R. Association of serotonin transporter gene polymorphism with efficacy of the anti-depressant drugs sertraline and mirtazapine in newly diagnosed patients with major depressive disorders. Hum. Psychopharmacol., 2022, 37(4), e2833.
[http://dx.doi.org/10.1002/hup.2833] [PMID: 35089613]

Poweleit, E.A.; Aldrich, S.L.; Martin, L.J.; Hahn, D.; Strawn, J.R.; Ramsey, L.B. Pharmacogenetics of sertraline tolerability and response in pediatric anxiety and depressive disorders. J. Child Adolesc. Psychopharmacol., 2019, 29(5), 348-361.
[http://dx.doi.org/10.1089/cap.2019.0017] [PMID: 31066578]

Brunoni, A.R.; Carracedo, A.; Amigo, O.M.; Pellicer, A.L.; Talib, L.; Carvalho, A.F.; Lotufo, P.A.; Benseñor, I.M.; Gattaz, W.; Cappi, C. As-sociation of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a dou-ble-blind, placebo-controlled trial. Br. J. Psychiatry, 2020, 42(2), 128-135.
[http://dx.doi.org/10.1590/1516-4446-2019-0620] [PMID: 31721892]

Camarena, B.; Álvarez-Icaza, D.; Hernández, S.; Aguilar, A.; Münch, L.; Martínez, C.; Becerra-Palars, C. Association study between serotonin transporter gene and fluoxetine response in mexican patients with major depressive disorder. Clin. Neuropharmacol., 2019, 42(1), 9-13.
[http://dx.doi.org/10.1097/WNF.0000000000000315] [PMID: 30520759]

Le François, B.; Czesak, M.; Steubl, D.; Albert, P.R. Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology, 2008, 55(6), 977-985.
[http://dx.doi.org/10.1016/j.neuropharm.2008.06.046] [PMID: 18639564]

Houston, J.P.; Zou, W.; Aris, V.; Fijal, B.; Chen, P.; Heinloth, A.N.; Martinez, J. Evaluation of genetic models for response in a randomized clinical trial of duloxetine in major depressive disorder. Psychiatry Res., 2012, 200(1), 63-65.
[http://dx.doi.org/10.1016/j.psychres.2012.06.002] [PMID: 22727709]

Zhao, X.; Huang, Y.; Li, J.; Ma, H.; Jin, Q.; Wang, Y.; Wu, L.; Zhu, G. Association between the 5-HT1A receptor gene polymorphism (rs6295) and antidepressants. Int. Clin. Psychopharmacol., 2012, 27(6), 1.
[http://dx.doi.org/10.1097/YIC.0b013e32835818bf] [PMID: 22890315]

Ochi, T.; Vyalova, N.M.; Losenkov, I.S.; Paderina, D.Z.; Pozhidaev, I.V.; Loonen, A.J.M.; Simutkin, G.G.; Bokhan, N.A.; Ivanova, S.A.; Wilffert, B. Limited associations between 5-HT receptor gene polymorphisms and treatment response in antidepressant treatment-free pa-tients with depression. Front. Pharmacol., 2019, 10, 1462.
[http://dx.doi.org/10.3389/fphar.2019.01462] [PMID: 31956308]

Ramesh, V.; Venkatesan, V.; Ramasamy, B. Role of serotonin transporter and receptor gene polymorphisms in treatment response to selec-tive serotonin reuptake inhibitors in major depressive disorder. Hum. Psychopharmacol., 2022, 37(4), e2830.
[http://dx.doi.org/10.1002/hup.2830] [PMID: 34994008]

Badamasi, I.M.; Lye, M.S.; Ibrahim, N.; Abdul Razaq, N.A.; Ling, K.H.; Stanslas, J. Serotonergic receptor gene polymorphism and response to selective serotonin reuptake inhibitors in ethnic Malay patients with first episode of major depressive disorder. Pharmacogenomics J., 2021, 21(4), 498-509.
[http://dx.doi.org/10.1038/s41397-021-00228-6] [PMID: 33731884]

Yuan, R.; Yuan, F.; Ren, D.; Zhu, Y.; Bi, Y.; Hu, J.; Guo, Z.; Xu, F.; Niu, W.; Wu, X.; Cao, Y.; Yang, F.; Wang, L.; Li, W.; Xu, Y.; He, L.; Yu, T.; He, G.; Li, X. HTR1A and HTR2A variants may not predict venlafaxine treatment response in China Han population with major depres-sive disorder. Psychiatry Res., 2018, 270, 1179-1180.
[http://dx.doi.org/10.1016/j.psychres.2018.10.038] [PMID: 30366640]

Alizadeh, N.; Nosrat, N.; Jahani, Z.; Ahmadiani, A.; Asadi, S.; Shams, J. Association of HTR1A gene polymorphisms with obsessive–compulsive disorder and its treatment response: The influence of sex and clinical characteristics. Int. J. Neurosci., 2019, 129(3), 264-272.
[http://dx.doi.org/10.1080/00207454.2018.1526799] [PMID: 30232922]

Klengel, T.; Binder, E.B. Gene × environment interactions in the prediction of response to antidepressant treatment. Int. J. Neuropsychopharmacol., 2013, 16(3), 701-711.
[http://dx.doi.org/10.1017/S1461145712001459] [PMID: 23237009]

Meyer, J.H.; Kapur, S.; Eisfeld, B.; Brown, G.M.; Houle, S.; DaSilva, J.; Wilson, A.A.; Rafi-Tari, S.; Mayberg, H.S.; Kennedy, S.H. The effect of paroxetine on 5-HT(2A) receptors in depression: An [(18)F]setoperone PET imaging study. Am. J. Psychiatry, 2001, 158(1), 78-85.
[http://dx.doi.org/10.1176/appi.ajp.158.1.78] [PMID: 11136637]

Fabbri, C.; Hosak, L.; Mössner, R.; Giegling, I.; Mandelli, L.; Bellivier, F.; Claes, S.; Collier, D.A.; Corrales, A.; Delisi, L.E.; Gallo, C.; Gill, M.; Kennedy, J.L.; Leboyer, M.; Lisoway, A.; Maier, W.; Marquez, M.; Massat, I.; Mors, O.; Muglia, P.; Nöthen, M.M.; O’Donovan, M.C.; Ospina-Duque, J.; Propping, P.; Shi, Y.; St Clair, D.; Thibaut, F.; Cichon, S.; Mendlewicz, J.; Rujescu, D.; Serretti, A. Consensus paper of the WFSBP task force on genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response. World J. Biol. Psychiatry, 2017, 18(1), 5-28.
[http://dx.doi.org/10.1080/15622975.2016.1208843] [PMID: 27603714]

Gassó, P.; Blázquez, A.; Rodríguez, N.; Boloc, D.; Torres, T.; Mas, S.; Lafuente, A.; Lázaro, L. Further support for the involvement of genetic variants related to the serotonergic pathway in the antidepressant response in children and adolescents after a 12-month follow-up: Impact of the HTR2A rs7997012 Polymorphism. J. Child Adolesc. Psychopharmacol., 2018, 28(10), 711-718.
[http://dx.doi.org/10.1089/cap.2018.0004] [PMID: 29975559]

Demirbugen Oz, M.; Uckun, Z.; Yuce-Artun, N.; Baskak, B.; Ozdemir, H.; Kizil Ozel, T.; Devrimci Ozguven, H.; Suzen, H.S. The relationship between the serotonin 2A receptor gene -1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients. Hum. Psychopharmacol., 2018, 33(5), e2673.
[http://dx.doi.org/10.1002/hup.2673] [PMID: 30221791]

Duman, R.S.; Voleti, B. Signaling pathways underlying the pathophysiology and treatment of depression: Novel mechanisms for rapid-acting agents. Trends Neurosci., 2012, 35(1), 47-56.
[http://dx.doi.org/10.1016/j.tins.2011.11.004] [PMID: 22217452]

Fabbri, C.; Corponi, F.; Albani, D.; Raimondi, I.; Forloni, G.; Schruers, K.; Kasper, S.; Kautzky, A.; Zohar, J.; Souery, D.; Montgomery, S.; Cristalli, C.P.; Mantovani, V.; Mendlewicz, J.; Serretti, A. Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2018, 81, 203-210.
[http://dx.doi.org/10.1016/j.pnpbp.2017.10.005] [PMID: 28989100]

Niitsu, T.; Fabbri, C.; Bentini, F.; Serretti, A. Pharmacogenetics in major depression: A comprehensive meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2013, 45, 183-194.
[http://dx.doi.org/10.1016/j.pnpbp.2013.05.011] [PMID: 23733030]

Ising, M.; Maccarrone, G.; Brückl, T.; Scheuer, S.; Hennings, J.; Holsboer, F.; Turck, C.; Uhr, M.; Lucae, S. FKBP5 gene expression predicts antidepressant treatment outcome in depression. Int. J. Mol. Sci., 2019, 20(3), 485.
[http://dx.doi.org/10.3390/ijms20030485] [PMID: 30678080]

Yang, C.; Li, S.; Ma, Y.; Chen, B.; Li, M.; Bosker, F.J.; Li, J.; Nolte, I.M. Lack of association of FKBP5 SNPs and haplotypes with suscepti-bility and treatment response phenotypes in han chinese with major depressive disorder. Medicine, 2021, 100(36), e26983.
[http://dx.doi.org/10.1097/MD.0000000000026983] [PMID: 34516490]

Nobile, B.; Ramoz, N.; Jaussent, I.; Dubois, J.; Guillaume, S.; Gorwood, P.; Courtet, P. Polymorphisms of stress pathway genes and emer-gence of suicidal ideation at antidepressant treatment onset. Transl. Psychiatry, 2020, 10(1), 320.
[http://dx.doi.org/10.1038/s41398-020-01003-0] [PMID: 32952155]

Tiwari, S.; Qi, L.; Wong, J.; Han, Z. Association of peripheral manifestation of brain‐derived neurotrophic factor with depression: A meta‐analysis. Brain Behav., 2022, 12(6), e32581.
[http://dx.doi.org/10.1002/brb3.2581] [PMID: 35510613]

Cocchi, E.; Fabbri, C.; Han, C.; Lee, S.J.; Patkar, A.A.; Masand, P.S.; Pae, C.U.; Serretti, A. Genome-wide association study of antidepressant response: Involvement of the inorganic cation transmembrane transporter activity pathway. BMC Psychiatry, 2016, 16(1), 106.
[http://dx.doi.org/10.1186/s12888-016-0813-x] [PMID: 27091189]

Chen, M.H.; Kao, C.F.; Tsai, S.J.; Li, C.T.; Lin, W.C.; Hong, C.J.; Bai, Y.M.; Tu, P.C.; Su, T.P. Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study. Genomics, 2021, 113(2), 507-514.
[http://dx.doi.org/10.1016/j.ygeno.2020.12.030] [PMID: 33370585]

Chen, M.H.; Lin, W.C.; Wu, H.J.; Cheng, C.M.; Li, C.T.; Hong, C.J.; Tu, P.C.; Bai, Y.M.; Tsai, S.J.; Su, T.P. Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD). J. Affect. Disord., 2019, 251, 162-169.
[http://dx.doi.org/10.1016/j.jad.2019.03.075] [PMID: 30925267]

Ochi, T.; Vyalova, N.M.; Losenkov, I.S.; Levchuk, L.A.; Osmanova, D.Z.; Mikhalitskaya, E.V.; Loonen, A.J.M.; Bosker, F.J.; Simutkin, G.G.; Bokhan, N.A.; Wilffert, B.; Ivanova, S.A. Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients. J. Affect. Disord., 2019, 259, 432-439.
[http://dx.doi.org/10.1016/j.jad.2019.08.058] [PMID: 31611000]

Martin, S.; Colle, R.; El Asmar, K.; Rigal, A.; Vievard, A.; Feve, B.; Becquemont, L.; Verstuyft, C.; Corruble, E. HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism. Psychol. Med., 2019, 49(14), 2364-2369.
[http://dx.doi.org/10.1017/S0033291718003240] [PMID: 30526722]

Zheng, X.; Fu, Z.; Chen, X.; Wang, M.; Zhu, R. Effects of ABCB1 gene polymorphism on the efficacy of antidepressant drugs. Medicine, 2021, 100(28), e26411.
[http://dx.doi.org/10.1097/MD.0000000000026411] [PMID: 34260525]

Magalhães, P.; Alves, G.; Fortuna, A.; Llerena, A.; Falcão, A. Pharmacogenetics and therapeutic drug monitoring of fluoxetine in a real-world setting: A PK/PD analysis of the influence of (non-)genetic factors. Exp. Clin. Psychopharmacol., 2020, 28(5), 589-600.
[http://dx.doi.org/10.1037/pha0000334] [PMID: 31750687]

Rahikainen, A.L.; Palo, J.U.; Haukka, J.; Sajantila, A. Post-mortem analysis of suicide victims shows ABCB1 haplotype 1236T–2677T–3435T as a candidate predisposing factor behind adverse drug reactions in females. Pharmacogenet. Genomics, 2018, 28(4), 99-106.
[http://dx.doi.org/10.1097/FPC.0000000000000328] [PMID: 29481489]

Simoons, M.; Mulder, H.; Appeldoorn, J.T.Y.; Risselada, A.J.; Schene, A.H.; van Schaik, R.H.N.; van Roon, E.N.; Ruhé, E.G. Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depres-sive disorder. Psychiatr. Genet., 2020, 30(1), 19-29.
[http://dx.doi.org/10.1097/YPG.0000000000000244] [PMID: 31634334]

Geers, L.M.; Ochi, T.; Vyalova, N.M.; Losenkov, I.S.; Paderina, D.Z.; Pozhidaev, I.V.; Simutkin, G.G.; Bokhan, N.A.; Wilffert, B.; Touw, D.J.; Loonen, A.J.M.; Ivanova, S.A. Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treat-ment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design. Hum. Psychopharmacol., 2022, 37(3), e2826.
[http://dx.doi.org/10.1002/hup.2826] [PMID: 34788473]

Pronk, A.C.; Seppala, L.J.; Trajanoska, K.; Stringa, N.; van de Loo, B.; de Groot, L.C.P.G.M.; van Schoor, N.M.; Koskeridis, F.; Mar-kozannes, G.; Ntzani, E.; Uitterlinden, A.G.; Rivadeneira, F.; Stricker, B.H.; van der Velde, N. Candidate genetic variants and antidepressant-related fall risk in middle-aged and older adults. PLoS One, 2022, 17(4), e0266590.
[http://dx.doi.org/10.1371/journal.pone.0266590] [PMID: 35421149]

Corponi, F.; Fabbri, C.; Boriani, G.; Diemberger, I.; Albani, D.; Forloni, G.; Serretti, A.; Corrected, Q.T. Corrected QT interval prolongation in psychopharmacological treatment and its modulation by genetic variation. Neuropsychobiology, 2019, 77(2), 67-72.
[http://dx.doi.org/10.1159/000493400] [PMID: 30544110]

Gu, M.; Li, A.; Mak, W.; Dong, F.; Xu, N.; Zhang, J.; Shi, Y.; Zheng, N.; Tang, Z.; He, Q.; Ruan, C.; Guo, W.; Xiang, X.; Wang, C.; Han, B.; Zhu, X. Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization. Front. Pharmacol., 2023, 14, 1089862.
[http://dx.doi.org/10.3389/fphar.2023.1089862] [PMID: 36744255]

Zhu, L.; Zheng, N.; Li, X.; Zhang, X. Hepatic artery and peripheral vein pharmacokinetics of raltitrexed in swine after the administration of a hepatic arterial infusion. Curr. Drug Metab., 2019, 20(7), 601-608.
[http://dx.doi.org/10.2174/1389200220666190618100847] [PMID: 31237202]

Zheng, N.; Lian, B.; Xu, G.; Liu, X.; Li, X.; Ji, J. Development of a subcellular semimechanism-based pharmacokinetic/pharmacodynamic model to characterize paclitaxel effects delivered by polymeric micelles. J. Pharm. Sci., 2019, 108(1), 725-731.
[http://dx.doi.org/10.1016/j.xphs.2018.10.062] [PMID: 30414867]